However, alpha-2 agonists profoundly alter cardiovascular function by producing bradycardia, hypertension followed by hypotension, decreased myocardial contractility, and dysarhythmias (Dart, 1999; Hall et al., 2001; Tranquilli et al., 2007; Plumb, 2008). This evidence concerns the gene PSMA2 and Hypertension.